Colorescience has closed a $10 million Series A convertible preferred stock offering from existing investors. The company also announced additions of two members to its board of directors, Josh Baltzell of Split Rock Partners and Howard Palefsky of Montreux Equity Partners.

Split Rock Partners, a venture capital firm focused on software, Internet services, and healthcare has promoted David Allison to principal in its Menlo Park office. Allison has been with the firm since 2009 and has focused on investments in the healthcare sector.

Waltham, Mass.-based regenerative medicine developer Histogenics Corp. wrapped up a $49 million Series A round, the company revealed Tuesday. Sofinnova Ventures led the big round, and was joined by a litany of backers: Split Rock Partners, BioMed Ventures and FinTech GIMV Fund, L.P. invested for the first time, and were joined by ProChon Holdings BV, [...]

Software developer Code 42 Software has appointed Kirk Bowman of Accel Partners to its board of directors. Bowman will provide strategic insight and guidance to Code 42 Software as the company continues accelerating product development and increasing global market share. His appointment follows Code 42′s $52.5 million first round of funding in January 2012 which [...]

Code 42 Software, developers of onsite, offsite and online backup solutions for consumers and businesses has secured $52.5 million in venture funding. Led by Accel Partners with participation from Split Rock Partners, the funding will be used to accelerate product development. PRESS RELEASE Code 42 Software Inc., developers of award-winning onsite, offsite and online backup [...]

DFINE Inc., a maker of minimally invasive radiofrequency targeted therapies for the treatment of vertebral pathologies, closed a $25 million. Investors include OrbiMed Advisors, Prospect Venture Partners, Split Rock Partners, BBT Fund/Apothecary Capital, Highland Capital Management and Vanguard Ventures.

RF Surgical Systems, a Bellevue, Wash.-based company whose technology keeps track of surgical sponges during hospital procedures (so they won’t get lost in patients), has closed on a $12 million round led by the healthcare-focused venture capital firm Split Rock Partners. Previous investors Menlo Ventures, Stanford University and two of the company founders also participated [...]

Leo de Luna has joined Split Rock Partners as a principal in its Menlo Park, Calif., offices. He will focus on identifying, evaluating and managing new later stage and secondary opportunities. He served most recently as a vice president at Saints Capital, a firm specializing in secondary direct investments. Earlier in his career, de Luna worked for St. Paul Venture Capital, and in technology investment banking at Lehman Brothers, and corporate development at Advanced Micro Devices.

Entellus Medical Inc., a medical device company focused on treatments for chronic sinusitis, has inked $35 million in fresh capital. Covidien Ventures led the round, which included existing investors SV Life Sciences, Essex Woodlands, Split Rock Partners and Greenspring Associates. The money will help Entellus continue efforts to commercialize the company’s products.

Transcend Medical Inc., a Menlo Park, Calif.-based ophthalmic device company, has closed a second tranche of its Series B round, bringing the total to an eye-popping $51 million. Investors include Investor Growth Capital, Canaan Partners, Finistere Ventures, HLM Venture Partners, Kaiser Permanente Ventures, Latterell Venture Partners, Morgenthaler Ventures, Split Rock Partners and Technology Partners. The company says it will use the funds to develop additional infrastructure and resources for a U.S. study of its micro-stent technology. The company is focused on minimally invasive glaucoma therapies.